Stocks · News reference
Organigram Global shares are trading higher after the company reported better-than-expected Q3 sales results and issued strong FY26 revenue guidance.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 11, 2026, 1:22 PM
- Checked
- Aug 11, 2026, 1:22 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
OrganiGram Holdings Q3 Sales $76.413M Beat $67.660M Estimate
OrganiGram Holdings (NASDAQ:OGI) reported quarterly sales of $76.413 million which beat the analyst consensus estimate of $67.660 million by 12.94 percent. This is a 49.41 percent increase over sales of $51.142 million
Read original at benzingaOrganigram Affirm Global FY2026 Revenue expected to be more than $255.197M vs $241.360M Est
Organigram Global (NASDAQ:OGI) affirm FY2026 Revenue expected to be more than $255.197M vs $241.360M Est
Read original at benzinga